semaglutide news today october 2025 FDA approves Wegovy pill New data show most patients

It's FDA approved for two main uses: chronic weight management in adults with obesity (or overweight plus a weight-related condition), and moderate to severe obstructive sleep apnea (OSA) in adults with obesity

Despite their undeniable slimming effects, injections of semaglutide - branded as Ozempic and Wegovy - have been linked to a catalogue of side effects from the embarrassing to potentially life-threatening.

60 capsules per bottle 30-day supply

Adoption is accelerating as therapies such as tirzepatide (Mounjaro) gain early traction, while semaglutide brands including Wegovy and Rybelsus continue expanding their presence following recent pricing adjustments

Consumers engaging with GLP-1 medications may also be making lifestyle changes and taking supplements to manage their needs